Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

NCT00543205 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to very slow enrollment

Conditions

Advanced Melanoma and Normal or Impaired
Hepatic Function

Interventions

DRUG: Genasense® (G3139, oblimersen sodium)

Sponsor

Genta Incorporated